London Cancer

London Cancer
Name	London Cancer
Location	London, England
Type	Specialist
Specialty	Oncology
Founded	2013

London Cancer is a collaborative cancer service network coordinating specialist oncology care across hospitals in United Kingdom's London. It integrates clinical delivery, research, and education among major institutions to standardize treatment pathways for patients with malignancies across NHS England regions. The network aligns multiple trusts, academic centres, and charities to deliver multidisciplinary care informed by trials and guidelines from national bodies.

Overview

London Cancer operates as a strategic partnership among leading hospitals, academic centres, and commissioning bodies to centralize specialist oncology expertise. Partner organisations include trusts and academic institutions such as Guy's and St Thomas' NHS Foundation Trust, Imperial College Healthcare NHS Trust, Royal Marsden NHS Foundation Trust, University College London Hospitals NHS Foundation Trust, and academic partners like King's College London and Imperial College London. The network collaborates with national organisations including NHS England, National Institute for Health and Care Excellence, and research funders such as Cancer Research UK and Medical Research Council. Its remit spans clinical pathways, workforce development, and alignment with regional strategic frameworks such as Sustainability and Transformation Plans and regional cancer alliances.

History

The network emerged from NHS reconfigurations and cancer strategy initiatives in the early 2010s, responding to priorities set by bodies like the National Cancer Action Team and policy documents from Department of Health and Social Care. Formalisation built on legacy centres with histories in oncology such as The Royal Marsden and specialist surgical units at St Thomas' Hospital and University College Hospital. Key milestones include integration of specialist services across trusts, adoption of national commissioning models advocated by NHS England and alignment with workforce reviews from organisations like Health Education England. The network evolved alongside major research programmes funded by Wellcome Trust and collaborative trials coordinated with groups like the National Institute for Health Research Clinical Research Network.

Services and Specialties

Services span multidisciplinary oncology disciplines including medical oncology, clinical oncology, surgical oncology, and supportive care. Subspecialties encompass thoracic oncology aligned with Royal Brompton Hospital collaborations, gastrointestinal oncology with links to St Mary’s Hospital, haematological malignancy services in partnership with specialist centres such as Hammersmith Hospital, and gynaecological oncology connected to units at King's College Hospital. The service model integrates diagnostic modalities from centres offering advanced imaging like Royal Free Hospital radiology departments, molecular pathology services collaborating with university labs at Queen Mary University of London, and specialised radiotherapy provision influenced by transfers from centres such as University College London Hospitals. Multidisciplinary team meetings draw participation from surgeons trained at Royal College of Surgeons, oncologists influenced by standards from Royal College of Radiologists, and specialist nurses accredited through programmes associated with Queen's Nursing Institute.

Research and Clinical Trials

Research activity is coordinated with academic partners including King's College London, Imperial College London, and University College London. London Cancer participates in investigator-led trials and commercial studies managed through the NIHR Clinical Research Network and academic collaborations funded by Cancer Research UK, Wellcome Trust, and European consortia prior to changes from European Union research frameworks. Research areas include precision oncology, immunotherapy trials connected to centres with expertise from The Institute of Cancer Research, translational science leveraging biobanks in partnership with Guy's and St Thomas' Biomedical Research Centre, and health services research informed by policy work from NHS Improvement. Clinical trial governance aligns with regulatory oversight by Medicines and Healthcare products Regulatory Agency and ethical review via NHS Research Ethics Committees.

Facilities and Locations

The network links major hospital sites and specialist centres across Greater London and surrounding boroughs. Principal sites include The Royal Marsden (Sutton and Chelsea), St Mary's Hospital, St Thomas' Hospital, Guy's Hospital, King's College Hospital, and UCLH Cancer Collaborative sites. Diagnostic and therapy hubs incorporate radiotherapy centres with equipment like linear accelerators located at specialist radiotherapy units formerly associated with Mount Vernon Hospital and other regional centres. Collaborative laboratory facilities exist at university campuses including Imperial College London Hammersmith Campus and Queen Mary University of London Whitechapel Campus.

Patient Care and Support Programs

Patient-facing services include multidisciplinary clinics, survivorship programmes modelled on guidance from NHS England, palliative care services with links to hospices such as Marie Curie and St Christopher's Hospice, and psychosocial support provided in collaboration with charities like Macmillan Cancer Support and Cancer Research UK. Navigation and information services align with standards from National Cancer Survivorship Initiative initiatives and incorporate patient involvement via groups associated with Healthwatch and local NHS patient participation frameworks. Rehabilitation pathways draw on community partnerships with organisations such as Sport England-linked projects and social care providers in London boroughs.

Governance and Funding

Governance involves partnership agreements among NHS trusts, oversight by regional commissioning bodies such as NHS England regional teams, and clinical leadership from designated cancer leads within trusts accredited by professional bodies including Royal College of Physicians and Royal College of Radiologists. Funding streams combine NHS commissioning, research grants from entities like Cancer Research UK and Medical Research Council, philanthropic donations via trusts and charities such as Wellcome Trust and hospital charities, and commercial income from industry-sponsored trials managed through the Healthcare Research Collaboration framework. Financial accountability adheres to national NHS financial reporting requirements and audit by statutory bodies including Care Quality Commission.

Category:Health in London